The Escalating Magnitude of COVID-19 Infections among the Northeastern Ethiopia Region: A Community-Based Cross-Sectional Study

Table 3

Trend of COVID-19 infection in the northeastern region of Ethiopia from July 01, 2020, to August 31, 2020, by different variables across each week (N = 291).

Parameters		Week 1	Week 2	Week 3	Week 4	Week 5	Week 6	Week 7	Week 8
Age, years
1–35	Negative	48 (0.8)	54 (0.9)	186 (3.1)	386 (6.5)	521 (8.8)	1317 (22.2)	2508 (42.3)	907 (15.3)
	Positive	0 (0)	0 (0)	0 (0)	6 (3.0)	17 (8.5)	20 (10)	104 (51.7)	54 (26.9)
36–52	Negative	14 (0.7)	14 (0.7)	21 (1.1)	124 (6.8)	108 (5.9)	330 (18.1)	819 (45.0)	390 (21.4)
	Positive	0 (0)	0 (0)	0 (0)	1 (1.7)	3 (5.0)	5 (8.3)	29 (48.3)	22 (36.7)
53–69	Negative	6 (1.0)	9 (1.5)	2 (0.3)	25 (4.4)	29 (5.0)	79 (14.0)	243 (43.2)	170 (30.2)
	Positive	0 (0)	0 (0)	0 (0)	1 (4.5)	0 (0)	3 (13.6)	9 (40.9)	9 (40.9)
70–86	Negative	2 (1.3)	4 (2.7)	0 (0)	1 (0.7)	8 (5.4)	28 (19.6)	52 (36.4)	48 (33.6)
	Positive	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	1 (16.7)	4 (66.7)	1 (16.7)
87–104	Negative	0 (0)	0 (0)	0 (0)	0 (0)	1 (12.5)	2 (25.0)	5 (62.5)	0 (0)
	Positive	0 (0)	0 (0)	0 (0)	0 (0)	1 (50.0)	0 (0)	0 (0)	1 (50.0)
Permanent residence by zone
Dessie town	Negative	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	28 (2.5)	527 (46.9)	668 (50.6)
	Positive	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	3 (5.8)	9 (17.3)	40 (76.9)
South Wollo	Negative	47 (1.0)	42 (0.9)	189 (4.2)	352 (7.9)	487 (10.9)	1147 (25.7)	1723 (38.6)	473 (10.6)
	Positive	0 (0)	0 (0)	0 (0)	2 (1.8)	15 (13.4)	8 (7.1)	73 (65.2)	14 (12.5)
Oromia Zone	Negative	5 (0.3)	10 (0.6)	20 (1.1)	88 (4.9)	119 (6.6)	201 (10.5)	947 (52.6)	422 (23.4)
	Positive	0 (0)	0 (0)	0 (0)	3 (3.3)	6 (6.5)	11 (12.0)	42 (45.7)	30 (32.6)
Wag Hemra	Negative	18 (1.8)	29 (3.0)	0 (0.0)	83 (8.7)	61 (6.2)	388 (40.6)	373 (39.0)	4 (0.4)
	Positive	0 (0)	0 (0)	0 (0)	1 (4.2)	0 (0)	7 (29.2)	16 (66.7)	0 (0)
Others	Negative	0 (0)	0 (0)	0 (0)	13 (10.7)	0 (0)	3 (2.5)	57 (47.1)	48 (39.7)
	Positive	0 (0)	0 (0)	0 (0)	2 (18.2)	0 (0)	0 (0)	6 (54.5)	3 (27.3)
Classification of study subjects for COVID-19 screening
New	Negative	70 (0.8)	80 (1.0)	209 (2.5)	536 (6.5)	667 (8.0)	1708 (20.6)	3564 (42.9)	1476 (17.8)
	Positive	0 (0)	0 (0)	0 (0)	8 (3.1)	21 (8.2)	28 (10.9)	132 (51.6)	67 (26.2)
Follow-up	Negative	0 (0)	1 (0.7)	0 (0)	0 (0)	0 (0)	48 (31.8)	63 (41.7)	39 (25.8)
	Positive	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	1 (2.9)	14 (40.0)	20 (57.1)
Reason for testing
Community surveillance	Negative	10 (0.1)	25 (0.4)	63 (0.9)	394 (5.8)	546 (8.0)	1618 (23.8)	3182 (46.7)	970 (14.2)
	Positive	0 (0)	0 (0)	0 (0)	6 (3.2)	9 (4.8)	19 (10.1)	108 (57.1)	47 (24.9)
Suspect	Negative	24 (2.5)	41 (4.3)	146 (15.3)	29 (3.0)	61 (6.6)	28 (3.0)	275 (29.9)	315 (34.3)
	Positive	0 (0)	0 (0)	0 (0)	0 (0)	6 (16.2)	9 (24.3)	14 (37.8)	8 (21.6)
Contact	Negative	36 (7.0)	14 (2.7)	0 (0)	46 (8.9)	60 (11.6)	62 (12.0)	107 (20.7)	191 (37.0)
	Positive	0 (0)	0 (0)	0 (0)	0 (0)	6 (21.4)	0 (0)	10 (35.7)	12 (42.9)
Facility-based survey	Negative	0 (0)	0 (0)	0 (0)	69 (100)	0 (0)	0 (0)	0 (0)	0 (0)
	Positive	0 (0)	0 (0)	0 (0)	2 (100)	0 (0)	0 (0)	0 (0)	0 (0)
Follow-up	Negative	0 (0)	1 (0.7)	0 (0)	0 (0)	0 (0)	49 (31.8)	63 (41.7)	39 (25.8)
	Positive	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	1 (2.9)	14 (40.0)	20 (57.1)